Home › Heart Failure › Louisiana › Shreveport
Heart Failure clinical trials in Shreveport, LA
4 studies for Heart Failure are looking for participants at sites in and around Shreveport (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
RecruitingPhase 3
- Grace Research, LLC-Shreveport-64616, Shreveport
- Grace Research, LLC-Bossier City-51040, Bossier City · 1 mi away
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
RecruitingPhase 3
- Research Site, Shreveport
- Research Site, Bossier City · 1 mi away
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RecruitingPhase 3
- Research Site, Shreveport
- Research Site, Bossier City · 1 mi away
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Grace Research, LLC_Shreveport, Shreveport
- Grace Research, LLC, Bossier City · 1 mi away
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA44 studies
- Dallas, TX42 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- Durham, NC26 studies
- St. Louis, MO26 studies
- Atlanta, GA25 studies
- Kansas City, MO25 studies
Other studies in Shreveport
- Breast Cancer8 studies
- Endometrial Cancer7 studies
- Ovarian Cancer7 studies
- Obesity7 studies
- Non-Small Cell Lung Cancer6 studies
- Cancer (all types)5 studies
- COPD5 studies
- Overweight4 studies
- Multiple Myeloma4 studies
- Cardiovascular Disease4 studies
- Steatotic Liver Disease3 studies
- Pneumococcal Infections3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.